Rapid Urease Test for Diagnosis of H. Pylori Infection in Patients With Peptic Ulcer Bleeding
NCT01282853 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 116
Last updated 2015-08-31
Summary
Rapid urease test (RUT) is the most commonly used biopsy-based method to diagnose Helicobacter pylori (Hp) infection because of its simple, rapid and accurate characters. However, its sensitivity was reported to decrease during ulcer bleeding recently. So it is an important issue to avoid a false negative test in these patients. Siddique et al reported that the sensitivity of RUT could be increased when the biopsy number increased from 1 to 4. Other studies demonstrated that additional biopsy from gastric body would increased the sensitivity of RUT in patients with ulcer bleeding. Therefore, we design this study to see if increased number of biopsy or different location of biopsy could increase sensitivity of RUT in patients with gastroduodenal ulcer bleeding.
After receiving explanation and giving consent, these patients with gastric or duodenal ulcer bleeding diagnosed after endoscopic examination will be enrolled. Those who are unstable, have received antibiotic or continuous proton pump inhibitor treatment within 4 weeks, or are contraindicated for endoscopic biopsy will be excluded. We will take 1 piece, 4 pieces of biopsy samples from prepyloric antrum and 1 piece from gastric body with standard biopsy forceps from the patients after they agree for RUT test. Then, we put these samples into 3 separate RUT kits respectively. We use 13C-UBT as gold standard for diagnosis of Hp infection. It is scheduled: (1) if the condition of this patient is not suitable for breath test just after endoscopic examination, 13C-UBT will be performed within 2 days,(2) otherwise, it will be performed 1 hour after examination. We plan to enroll 100 patients for this study. We will apply McNamer's test to examine the difference of RUT sensitivity of different biopsy number. For the RUT sensitivity from different locations, we use kappa statistic method to analyze their consistency.
Conditions
- Peptic Ulcer
- Hemorrhage
Interventions
- PROCEDURE
-
endoscopic biopsy
endoscopic biopsy for rapid urease test
- PROCEDURE
-
endoscopic biopsy
endoscopic biopsy for rapid urease test
- PROCEDURE
-
endoscopic biopsy
endoscopic biopsy for rapid urease test
Sponsors & Collaborators
-
Far Eastern Memorial Hospital
lead OTHER
Principal Investigators
-
Tzong-Hsi Lee, MD · Far Eastern Memorial Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-08-31
- Primary Completion
- 2011-06-30
- Completion
- 2011-06-30
Countries
- Taiwan
More Related Trials
-
Comparison of Different Helicobacter Pylori Detection Methods in Patients With Chronic Atrophic Gastritis
NCT04923113 ·Status: COMPLETED ·Phase: NA
-
Sensitivity and Specificity of the Modified Helicobacter Test INFAI
NCT04294823 ·Status: WITHDRAWN
-
Diagnostic Performance of CIM for Helicobacter Pylori Infection in Patients With Peptic Ulcer Bleeding
NCT06273384 ·Status: NOT_YET_RECRUITING
-
Intrafamilial Helicobacter Pylori Infection in Hong Kong
NCT06425393 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
UBT as a Diagnostic Tool for HP Prevalance
NCT02570776 ·Status: UNKNOWN
-
Detection of Helicobacter Pylori in Ulcerative Colitis Patients
NCT03172000 ·Status: UNKNOWN ·Phase: NA
-
Lymphocytic Subsets and Cytokine Production With H. Pylori Infection
NCT00173953 ·Status: COMPLETED ·Phase: NA
-
Presence or Absence of Blood in the GI Lumen
NCT05415124 ·Status: COMPLETED ·Phase: NA
-
Pepsinogens as the Early Marker of H. Pylori Eradication
NCT00197457 ·Status: COMPLETED ·Phase: PHASE2
-
Immediate Detection of Helicobacter Infection With a New Electrochemical System.
NCT01234389 ·Status: COMPLETED ·Phase: NA
-
Gastrin, Anti-helicobacter Pylori and Pepsinogen Diagnostic Accuracy Study
NCT07060482 ·Status: NOT_YET_RECRUITING
-
Blood Tests for Gastritis and Gastric Neoplasms
NCT05883345 ·Status: COMPLETED
-
The Revolutions of Helicobacter Pylori Infection, Bacterial Density, and Histological Features After Antrectomy
NCT00441831 ·Status: UNKNOWN
-
The Selection Criteria for the Second-look Endoscopy Among Patients With Bleeding Peptic Ulcers
NCT02197039 ·Status: COMPLETED
-
Symptom Assessment for GERD Patients Receiving H. Pylori Eradication
NCT01249482 ·Status: UNKNOWN
-
The Diagnostic Validity of the Urea Breath Test
NCT02359942 ·Status: COMPLETED ·Phase: NA
-
HELicobacter Pylori Screening to Prevent Gastrointestinal Bleeding in Patients With Acute Myocardial Infarction
NCT05024864 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Optimal Recheck Time for Helicobacter Pylori Eradication: A Prospective Randomized Trial
NCT05870397 ·Status: UNKNOWN ·Phase: NA
-
Helicobacter Pylori 23S rRNA/gyrA Gene Mutation Detection Kit (Fluorescence PCR Fusion Curve Method)
NCT05410652 ·Status: COMPLETED
-
Detection of Helicobacter Pylori Infection by High Resolution Endoscopy
NCT01434992 ·Status: COMPLETED
-
Pepsinogen II and Helicobacter Pylori Test in Gastric Cancer
NCT06301464 ·Status: ACTIVE_NOT_RECRUITING
-
H. Pylori Testing for Patients With Non-specific Upper Abdominal Pain in the Emergency Department
NCT01376414 ·Status: COMPLETED
-
Gamma-Glutamyl Transpeptidase (GGT): A Potential Diagnostic Marker for Helicobacter Pylori Infections
NCT02123771 ·Status: UNKNOWN
-
Association of Oral Helicobacter Pylori Infection With Gastric Helicobacter Pylori Infection
NCT05790512 ·Status: COMPLETED
-
Screening Strategy for Gastric Cancer Prevention
NCT05387005 ·Status: RECRUITING ·Phase: NA